Management would say, We look forward to engaging with regulatory agencies to finalize our Phase 3 development plans in the months ahead, as we aim to expand our reach and make setmelanotide available to the approximately 5,000 to 10,000 people living with hypothalamic obesity in the United States. A number of sell side notes came out after this news with Stifel saying they think positive safety and efficacy data from the remaining patients in fall 2022 could pave the way for constructive discussions with regulators in 2H22
Home, office, or hotel nationwide delivery available
HDL, the good cholesterol, helps remove excess cholesterol and transports it back to the liver
LPS administration induced significant phosphorylation of NF-B p65 (Ser536), p38 MAPK, and JNK1/2 in lung homogenates
Its full of healthy and satisfying ingredients
Megan S appreciated the slimming effects the treatment had on her face and tummy, while Alex R